emergency use authorization
Maxim Biomedical OTC COVID-19 Antigen Test Nabs FDA Emergency Use Authorization
The test delivers results in 15 minutes and is for identifying the SARS-CoV-2 nucleocapsid protein antigen in symptomatic and asymptomatic individuals.
Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets FDA EUA
The high-throughput test combines CRISPR technology with an automated liquid handling platform from Agilent.
The firm now has two FDA authorized SARS-CoV-2 antigen tests, and it recently nabbed a large contract as part of the US government free-test program.
IHealth Point-of-Care SARS-CoV-2 Antigen Test Receives FDA EUA
The test qualitatively detects SARS-CoV-2 nucleocapsid antigens from anterior nasal swab samples and can be used by symptomatic or asymptomatic people.
FDA Grants Emergency Use Authorization for Premier Medical COVID-19 Test
The PCR-based test uses nasal swab specimens collected with the INeedaCOVID19Test.com Self Collection Kit.